# ATORVASTATIN CALCIUM
> **ANDA212103** · Abbreviated New Drug Application (Generic) · Sponsor: CADILA PHARMS LTD · Approved 2023-10-16
## Drug
- **FDA Application Number:** ANDA212103
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATORVASTATIN CALCIUM
- **Generic name:** ATORVASTATIN CALCIUM
- **Active ingredients:** ATORVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CADILA PHARMS LTD
- **Manufacturer:** Cadila Pharmaceuticals Limited
- **First approval:** 2023-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212103)
---
*AI Analytics · CC0 1.0*